Share Name Share Symbol Market Type Share ISIN Share Description
Hutchison China Meditech LSE:HCM London Ordinary Share KYG4672N1016 ORD USD1
  Price Change % Change Share Price Shares Traded Last Trade
  -310.00p -6.42% 4,515.00p 28,933 16:29:39
Bid Price Offer Price High Price Low Price Open Price
4,480.00p 4,550.00p 4,760.00p 4,490.00p 4,760.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 178.6 -39.6 -31.8 - 2,742.87

Hutchison China Meditech (HCM) Latest News

More Hutchison China Meditech News
Hutchison China Meditech Takeover Rumours

Hutchison China Meditech (HCM) Share Charts

1 Year Hutchison China Meditech Chart

1 Year Hutchison China Meditech Chart

1 Month Hutchison China Meditech Chart

1 Month Hutchison China Meditech Chart

Intraday Hutchison China Meditech Chart

Intraday Hutchison China Meditech Chart

Hutchison China Meditech (HCM) Discussions and Chat

Hutchison China Meditech Forums and Chat

Date Time Title Posts
23/3/201816:09(Chi-Med)Hutchinson China Meditech Limited1,356
13/6/201706:54Hutchison China Meditech- CHARTS AND DISCUSSION74

Add a New Thread

Hutchison China Meditech (HCM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Hutchison China Meditech trades in real-time

Hutchison China Meditech (HCM) Top Chat Posts

Hutchison China Meditech Daily Update: Hutchison China Meditech is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchison China Meditech was 4,825p.
Hutchison China Meditech has a 4 week average price of 4,490p and a 12 week average price of 4,305p.
The 1 year high share price is 5,920p while the 1 year low share price is currently 2,857.50p.
There are currently 60,750,132 shares in issue and the average daily traded volume is 18,438 shares. The market capitalisation of Hutchison China Meditech is £2,742,868,459.80.
dbadvn: Had a very interesting meeting with the CFO . They are certainly sticking to plan and gearing up for European/US sales independently of whatever happens with Lilley etc. Making all the right noises on Clinical/ Sales teams/ Branding/ Competition and realistic on timescale. Not defending the fact that the recent cash raise was basically opportunistic use of perfect market conditions . Looking to be cash flow positive within 5 years ( doe not exclude more cash raising depending on opportunities). The positive "elephant in the room" is the $50bn potential of HMPL 523 in the immunology market. Although still at the early stages HCM seem to have the lead here and only Gilead as competition. Short term lack of news flow may see the share price drift but medium and long term potential probabilities of success are increasing . At some point the US market will start to valur HCM in the same way as the US Biotechs ( less the takeover premium perhaps ) .At that point the share price will react strongly . When that happens is anyones guess so I for one am staying invested long term
nerdofsteel: mad - agree 100%, and if you look back at the share price in London over the last 10 years you see sometimes quite lengthy periods where the share price is stagnant, followed by sharp increases, then further stagnation
reptile3: Short interest on the NASDAQ is 326.25k shares which I assume is significant and affecting the share price today.
its the oxman: Little bit of strength returning to the share price?
lauders: Well I thought the RNS today was worth a bit of reaction re: the share price. Obviously not but odd it is not showing in the header: Https://
lauders: Thank you Nerdofsteel. Appreciate the feedback. Your reply makes sense, so it could be a win-win. If positive the share price will likely increase in turn, if negative it will drop but allow those with the future in mind to add more and benefit from marketing freely and perhaps penning an alternative deal. Can Lilly risk the latter? Now let's just see what the Nasdaq does today. If it is a good day the share price will recover. If not we could be going down again.
carcosa: Why do you need reassuring? Recent share price decline is in line with world stock market changes.
lauders: Perhaps foolish but I bought in on this dip! Seems too steep so either bad news is on the way or it is just a major correction on a frothy share price and is due a change in direction soon. Obviously I am hoping for the latter! RSI makes it a buy at least. One of the things I found during my due diligence into HCM: Https:// I wasn't aware of the video before even if it is a bit dated now.
nerdofsteel: Frustrating price drift on NASDAQ which I suspect is simply down to the lack of news for the last few months. In my long experience of investing in the Company, we've had periods like this, and often when material news comes it comes in waves. I also notice when there's a long quiet period when we do get news it's usually extremely interesting and very very material, causing a significant positive impact on the share price.
mad foetus: Amazing that nobody notices this company - incredible share price record, incredible prospects, massive positive response to fund raising, share price sharply up and nobody notices. LOL!
Hutchison China Meditech share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180323 20:55:47